Javascript must be enabled to continue!
THERANOSTICS AS A TOOL FOR PRECISION MEDICINE: INTEGRATION OF DIAGNOSIS AND THERAPY IN CLINICAL APPLICATION
View through CrossRef
Background: The term theranostics, coined in 1998, refers to the seamless integration of diagnostics and therapeutics into a single unified framework. By combining these two traditionally separate domains, theranostics eliminates redundant procedures, streamlines clinical decision-making, and reduces the burden on public health systems while improving patient outcomes. Objectives: This review examines the expanding role of theranostics in personalized medicine, with particular focus on oncological applications — notably prostate cancer and neuroendocrine tumors — highlighting how theranostic strategies deliver precise, individualized treatment while minimizing unnecessary and costly interventions. Methods: A comprehensive literature search was conducted across Google Scholar, PubMed, and ScienceDirect using keywords including theranostics, diagnostic imaging in theranostics, and theranostics applications. Relevant peer-reviewed articles were selected based on relevance, scientific rigor, and recency. Results: Advanced imaging modalities — Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), and Single Photon Emission Computed Tomography (SPECT) — have been successfully integrated into theranostic frameworks. Six key oncological biomarkers — Neuron-Specific Enolase (NSE), Carcinoembryonic Antigen (CEA), Prostate-Specific Antigen (PSA), Squamous Cell Carcinoma Antigen (SCCA), Carbohydrate Antigen 19-9 (CA19-9), and Tumor Protein 53 (TP53) — serve as critical diagnostic indicators. Boron-Dipyrromethene (BODIPY) has emerged as a promising multimodal agent for simultaneous tumor visualization and treatment. Nanoparticle-based Photothermal Therapy (PTT) and Photodynamic Therapy (PDT) offer targeted therapeutic precision. Radiotheranostics employs radionuclides for dual diagnostic and therapeutic purposes. Conclusion: Theranostics represents a transformative paradigm in modern oncology, merging diagnosis and therapy into a patient-centered strategy. By personalizing treatment plans, significantly reducing healthcare costs, minimizing procedural burden, and maximizing clinical outcomes, theranostics positions itself as a cornerstone of next-generation precision medicine.
Superior University, Lahore
Title: THERANOSTICS AS A TOOL FOR PRECISION MEDICINE: INTEGRATION OF DIAGNOSIS AND THERAPY IN CLINICAL APPLICATION
Description:
Background: The term theranostics, coined in 1998, refers to the seamless integration of diagnostics and therapeutics into a single unified framework.
By combining these two traditionally separate domains, theranostics eliminates redundant procedures, streamlines clinical decision-making, and reduces the burden on public health systems while improving patient outcomes.
Objectives: This review examines the expanding role of theranostics in personalized medicine, with particular focus on oncological applications — notably prostate cancer and neuroendocrine tumors — highlighting how theranostic strategies deliver precise, individualized treatment while minimizing unnecessary and costly interventions.
Methods: A comprehensive literature search was conducted across Google Scholar, PubMed, and ScienceDirect using keywords including theranostics, diagnostic imaging in theranostics, and theranostics applications.
Relevant peer-reviewed articles were selected based on relevance, scientific rigor, and recency.
Results: Advanced imaging modalities — Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), and Single Photon Emission Computed Tomography (SPECT) — have been successfully integrated into theranostic frameworks.
Six key oncological biomarkers — Neuron-Specific Enolase (NSE), Carcinoembryonic Antigen (CEA), Prostate-Specific Antigen (PSA), Squamous Cell Carcinoma Antigen (SCCA), Carbohydrate Antigen 19-9 (CA19-9), and Tumor Protein 53 (TP53) — serve as critical diagnostic indicators.
Boron-Dipyrromethene (BODIPY) has emerged as a promising multimodal agent for simultaneous tumor visualization and treatment.
Nanoparticle-based Photothermal Therapy (PTT) and Photodynamic Therapy (PDT) offer targeted therapeutic precision.
Radiotheranostics employs radionuclides for dual diagnostic and therapeutic purposes.
Conclusion: Theranostics represents a transformative paradigm in modern oncology, merging diagnosis and therapy into a patient-centered strategy.
By personalizing treatment plans, significantly reducing healthcare costs, minimizing procedural burden, and maximizing clinical outcomes, theranostics positions itself as a cornerstone of next-generation precision medicine.
Related Results
ecision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predi
ecision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predictive Analytics in Precision Farming and Predi
The scope of sensor networks and the Internet of Things spanning rapidly to diversified domains but not limited to sports, health, and business trading. In recent past, the sensors...
Exploring Large Language Models Integration in the Histopathologic Diagnosis of Skin Diseases: A Comparative Study
Exploring Large Language Models Integration in the Histopathologic Diagnosis of Skin Diseases: A Comparative Study
Abstract
Introduction
The exact manner in which large language models (LLMs) will be integrated into pathology is not yet fully comprehended. This study examines the accuracy, bene...
Optimising tool wear and workpiece condition monitoring via cyber-physical systems for smart manufacturing
Optimising tool wear and workpiece condition monitoring via cyber-physical systems for smart manufacturing
Smart manufacturing has been developed since the introduction of Industry 4.0. It consists of resource sharing and networking, predictive engineering, and material and data analyti...
Applying a user-centered approach to evaluate the usability of a mobile application for health professionals in home care services (Preprint)
Applying a user-centered approach to evaluate the usability of a mobile application for health professionals in home care services (Preprint)
BACKGROUND
Mobile health (mHealth), or the use of mobile devices in medicine and health, is a sub-category of e-health. mHealth interventions are designed t...
Proceedings of the Qatar Paediatric Emergency Medicine 2026 Conference - Selected Abstracts
Proceedings of the Qatar Paediatric Emergency Medicine 2026 Conference - Selected Abstracts
Welcome to this issue of Panorama of Emergency Medicine (POEM) dedicated to the 10th Qatar Paediatric Emergency Medicine (Q-PEM) International Conference which was organised and ho...
Theranostics in the Arab World; Achievements & Challenges
Theranostics in the Arab World; Achievements & Challenges
In nuclear medicine, theranostics (combining therapy and diagnostics in one platform) is made possible through the utilization of radiopharmaceuticals for both therapeutic and diag...
The Use of Medicinal Plant-Derived Metallic Nanoparticles in Theranostics
The Use of Medicinal Plant-Derived Metallic Nanoparticles in Theranostics
In the quest to effectively diagnose and treat the diseases that afflict mankind, the development of a tool capable of simultaneous detection and treatment would provide a signific...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...

